Li, Xinyang
Jiang, Xiao
Kou, Ying
He, Yu
Yi, Jingkai
Wang, Dan
Qi, Kailin
Li, Yingchun
Wu, Ping
Yao, Yutang
Lu, Hao
Chen, Shirong
Zhao, Meng
Cao, Zhen
Cheng, Zhuzhong
Article History
Received: 8 October 2025
Accepted: 6 January 2026
First Online: 17 January 2026
Declarations
:
: This study was approved by the Ethics Committee of Sichuan Cancer Hospital (approval number: SCCSMC-01–202-87) and conducted in compliance with Chinese regulations. The study was registered in the Chinese Clinical Trial Registry (ChiCTR2400090595) on October 9, 2024. All participants provided written informed consent prior to enrollment. The research was conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.